REMEGEN (09995) intends to elect directors for the third session of the board of directors.
Rongchang Biotechnology (09995) announced that the board of directors convened a meeting on May 18, 2026, to propose the election of directors for the third session of the board (excluding independent non-executive directors).
REMEGEN (09995) announced that the Board of Directors held a meeting on May 18, 2026, to recommend the election of directors for the third term of the Board of Directors (excluding independent non-executive directors).
After considering the recommendations made by the Nomination Committee of the Board of Directors based on the Company's nomination policy and board diversity policy, the Board of Directors decided to nominate Mr. Wang Weidong, Dr. Fang Jianmin, Mr. Wen Qingkai, Ms. Fang Yi, and Mr. Wang Liqiang as candidates for non-independent directors of the third term of the Board of Directors. Among them, Mr. Wang Weidong, Dr. Fang Jianmin, Mr. Wen Qingkai, and Ms. Fang Yi are candidates for executive directors, while Mr. Wang Liqiang is a candidate for non-executive director.
The Board of Directors decided to submit the list of the above non-independent director candidates for shareholders' consideration and approval at the annual general meeting. The term of the third term of the Board of Directors is three years. The term of each of the above non-independent director candidates will take effect from the date of their appointment approved by the shareholders at the annual general meeting.
The Board of Directors held a meeting on May 18, 2026, to recommend the election of independent non-executive directors for the third term of the Board of Directors.
After considering the recommendations made by the Nomination Committee based on the Company's nomination policy and board diversity policy, the Board of Directors decided to nominate Mr. Song Xiliang, Mr. Chen Yunjin, and Mr. Huang Guobin as candidates for independent non-executive directors of the third term of the Board of Directors. Mr. Song Xiliang, Mr. Chen Yunjin, and Mr. Huang Guobin each confirmed that they meet the independence criteria set out in Rules 3.13(1) to (8) of the Listing Rules of the Stock Exchange of Hong Kong (HKEX), and have no financial or other interests in the Company or its affiliates, or any relations with any core related persons of the Company, and there are no other factors that may affect their independence at the time of appointment.
The Board of Directors decided to submit the list of the above independent non-executive director candidates for shareholders' consideration and approval. The term of the third term of the Board of Directors is three years. The term of each of the above independent non-executive director candidates will take effect from the date of their appointment approved by the shareholders at the annual general meeting.
Related Articles

New Stock News | Jin Sheng New Energy Second Delisting Plan on Hong Kong Stock Exchange

Dow Jones weaken, so what to fear? Ahbenheimer strongly believes that the bull market for the seven tech giants in the US stock market is not over.

MANYCORE TECH (00068): Stable price action and end of stable price period.
New Stock News | Jin Sheng New Energy Second Delisting Plan on Hong Kong Stock Exchange

Dow Jones weaken, so what to fear? Ahbenheimer strongly believes that the bull market for the seven tech giants in the US stock market is not over.

MANYCORE TECH (00068): Stable price action and end of stable price period.






